Testing effectiveness (Phase 2)Active Not RecruitingNCT05021237
What this trial is testing
Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer
Who this might be right for
Stage IV Cervical Cancer FIGO 2018Adenosquamous Carcinoma of CervixCervical Cancer+1 more
University of Texas Southwestern Medical Center 12